Designing Longevity
Skip to main content

Probiotics, Microbiome Tests and Gut Product Claims

A probiotic claim is useful only when it specifies the strain or combination, the population and the outcome studied. A consumer stool profile can describe a sample, but its usefulness for choosing treatment needs separate evidence.

Sources reviewed November 13, 2026 · How we work

Match the exact product to the claim

Look at the strain names, any identification codes and the full formulation. Results for one strain or combination may not apply to another. Then check whether the study measured a symptom that matters to you, such as fewer episodes of diarrhea, or only a change in the lab.

Microbiome researchers study relationships between stool microbes and disease. An expert consensus found limited evidence supporting routine clinical use of microbiome testing. A consumer score has no established role in diagnosing IBS, celiac disease or inflammatory bowel disease.

Sources for this section

Diarrhea during or after antibiotics

Antibiotic-associated diarrhea has several causes. Studies of all-cause diarrhea and studies of confirmed C. difficile infection answer different questions. A 2020 AGA guideline conditionally suggested certain probiotic formulations for C. difficile prevention during antibiotics, while a 2021 ACG guideline recommended against routine probiotic use for that purpose.

New or persistent diarrhea during or after antibiotics may warrant evaluation for C. difficile. FDA-approved fecal microbiota products have specific clinical uses to prevent recurrence following antibiotic treatment for recurrent C. difficile infection.

Sources for this section
Explore Gut Health & Digestion